View Author
Goodman, S.G.
( S.G. Goodman)
patient infarction study heparin group enoxaparin streptokinase artery q-wave thrombolysi –q mi tissue plasminogen activator therapy angiographic unfractionated heparin –q mi patients thrombolytic heart infarct st-segment elevation grade patency placebo trial reperfusion treatment analysis unfractionated mortality st-segment hospital thrombolytic therapy difference ejection fraction elevation placebo group infarct-related table gusto-i investigator resolution outcome eur heart j efficacy comparison angiography event reocclusion aspirin non-q wave infarct size 180 min plasminogen follow-up ecg angina reinfarction infarct-related artery activator death finding prognosis follow-up tissue function university q-wave mi value st-segment resolution safety revascularization substudy q-wave mi patients 90 min 7 days goodman alteplase wall motion cardiol artery disease haemorrhage
2 Most Recent Publications
|
Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study
(Article)
Krzeminska-Pakula, M. Alonso, A. Goodman, S.G. Kali, A. Loos, U. Gosset, F. Louer, V. Bigonzi, F. Simoons, M.L. |
2002-01-01
|
|
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators
(Article)
Goodman, S.G. Topol, E.J. Granger, C.B. Califf, R.M. Armstrong, P.W. Simoons, M.L. Langer, A. Ross, A.M. Wildermann, N.M. Barbagelata, A. Sgarbossa, E.B. Wagner, G.S. |
1998-01-01
|